Exactus (OTCMKTS:EXDI) and Vivint Solar (NYSE:VSLR) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their profitability, institutional ownership, dividends, risk, earnings, analyst recommendations and valuation.

Institutional and Insider Ownership

89.4% of Vivint Solar shares are owned by institutional investors. 52.9% of Exactus shares are owned by insiders. Comparatively, 4.2% of Vivint Solar shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Analyst Ratings

This is a breakdown of current ratings for Exactus and Vivint Solar, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Exactus 0 0 0 0 N/A
Vivint Solar 0 0 3 0 3.00

Vivint Solar has a consensus price target of $6.00, indicating a potential upside of 11.11%. Given Vivint Solar’s higher probable upside, analysts clearly believe Vivint Solar is more favorable than Exactus.

Volatility and Risk

Exactus has a beta of 1.11, meaning that its share price is 11% more volatile than the S&P 500. Comparatively, Vivint Solar has a beta of -0.36, meaning that its share price is 136% less volatile than the S&P 500.

Earnings and Valuation

This table compares Exactus and Vivint Solar’s gross revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Exactus N/A N/A -$3.86 million N/A N/A
Vivint Solar $268.03 million 2.39 $209.09 million ($1.58) -3.42

Vivint Solar has higher revenue and earnings than Exactus.

Profitability

This table compares Exactus and Vivint Solar’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Exactus N/A N/A -6,194.12%
Vivint Solar 61.71% -50.31% -11.01%

Summary

Vivint Solar beats Exactus on 7 of the 10 factors compared between the two stocks.

About Exactus

Exactus, Inc. is a life science company, which engages in developing and commercializing Point-of-Care (POC) diagnostics for measuring proteolytic enzymes in the blood based on a novel detection platform. It operates under the FibriLyzer and MatriLyzer trademarks. The company was founded on January 18, 2008 and is headquartered in Glen Allen, VA.

About Vivint Solar

Vivint Solar, Inc. provides distributed solar energy to residential, commercial, and industrial customers in the United States. The company operates in two segments, Residential, and Commercial and Industrial. It owns and installs solar energy systems through long-term customer contracts. The company also sells photovoltaic installation products, as well as solar renewable energy certificates. As of December 31, 2017, it had an aggregate capacity of 864.9 megawatts covering approximately 126,800 homes in 21 states. The company was formerly known as V Solar Holdings, Inc. and changed its name to Vivint Solar, Inc. in April 2014. Vivint Solar, Inc. was founded in 2011 and is headquartered in Lehi, Utah.

Receive News & Ratings for Exactus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exactus and related companies with MarketBeat.com's FREE daily email newsletter.